Top

Published in:

01-06-2011 | Original Article

Patent Ductus Arteriosus in the Preterm Infant: A Survey of Clinical Practices in French Neonatal Intensive Care Units

Authors: Olivier Brissaud, Julie Guichoux

Published in: Pediatric Cardiology | Issue 5/2011

Abstract

Patent ductus arteriosus (PDA) is one of the most common problems in the care of premature infants, especially the extremely premature. There is no real consensus regarding the diagnostic criteria or treatment of a hemodynamically significant PDA. Its diagnosis, assessment, and treatment still remain challenges. Therefore, we investigated clinical practices in French tertiary neonatology centers regarding the management of PDA to compare their similarities and differences. We sent a questionnaire by email to the PDA specialist in every French tertiary neonatal intensive care unit. It contained 27 items regarding the unit’s structure, method of diagnosing PDA, and treatment choices. The completed questionnaire were returned via email and analyzed blindly. The questionnaire response rate was 87.5%, which allowed us to draw some conclusions regarding French clinical practices in the care of neonates with PDA. Although the diagnostic criteria are quite similar, the therapeutic practices are rather different across neonatal care units. We highlight the great variability in French clinical practices when it comes to treating PDA and underscore the necessity for harmonization of these practices, which could be achieved using multicenter, randomized studies to identify the advantages of one approach compared with another.

Alagarsamy S, Chhabra M, Gudavalli M, Nadroo AM, Sutija VG, Yugrakh D (2005) Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med 33:161–164PubMedCrossRef

Aranda JV, Varvarigou A, Beharry K, Bansal R, Bardin C, Modanlou H et al (1997) Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 86:289–293PubMedCrossRef

Bose CL, Laughon MM (2007) Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 92:F498–F502PubMedCrossRef

Brooks JM, Travadi JN, Patole SK, Doherty DA, Simmer K (2005) Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 90:F235–F239PubMedCrossRef

Chorne N, Leonard C, Piecuch R, Clyman RI (2007) Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 119:1165–1174PubMedCrossRef

Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR (2000) The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 106:659–671PubMedCrossRef

Davis P, Turner-Gomes S, Cunningham K, Way C, Roberts R, Schmidt B (1995) Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus. Arch Pediatr Adolesc Med 149:1136–1141PubMed

Desfreres L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G et al (2005) Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharmacol Ther 30:121–132CrossRef

El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419–F422PubMedCrossRef

10.

Evans N (1993) Diagnosis of patent ductus arteriosus in the preterm newborn. Arch Dis Child 68:58–61PubMedCrossRef

11.

Evans N (2000) Echocardiography on neonatal intensive care units in Australia and New Zealand. J Paediatr Child Health 36:169–171PubMedCrossRef

12.

Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM et al (2004) Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 364:1939–1944PubMedCrossRef

13.

Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ et al (2008) An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 65:629–636PubMedCrossRef

14.

Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A (2007) Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 150:229–234 34 e1PubMedCrossRef

15.

Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127:774–779PubMedCrossRef

16.

Kluckow M, Evans N, Osborn D, Paradisi M, Gill A (2008) Ductal diameter is determined more by postnatal age than gestational age. E-PAS 2008:635842.7

17.

Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117:1113–1121PubMedCrossRef

18.

Kupferschmid C, Lang D, Pohlandt F (1988) Sensitivity, specificity and predictive value of clinical findings, m-mode echocardiography and continuous-wave Doppler sonography in the diagnosis of symptomatic patent ductus arteriosus in preterm infants. Eur J Pediatr 147:279–282PubMedCrossRef

19.

Laughon MM, Simmons MA, Bose CL (2004) Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 16:146–151PubMedCrossRef

20.

Lyer P, Evans N (1994) Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 70:F112–F117CrossRef

21.

Madan JC, Kendrick D, Hagadorn JI, Frantz ID 3rd (2009) Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 123:674–681PubMedCrossRef

22.

Malviya M, Ohlsson A, Shah S (2008) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev CD003951

23.

McNamara PJ, Sehgal A (2007) Toward rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed 92(6):F424–F427PubMedCrossRef

24.

Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I et al (2009) Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123:e138–e144PubMedCrossRef

25.

Raval MV, Laughon MM, Bose CL, Phillips JD (2007) Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost? J Pediatr Surg 42:69–75PubMedCrossRef

26.

Shah SS, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev CD004213

27.

Skelton R, Evans N, Smythe J (1994) A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 30:406–411PubMedCrossRef

28.

Suzumura H, Nitta A, Tanaka G, Arisaka O (2001) Diastolic flow velocity of the left pulmonary artery of patent ductus arteriosus in preterm infants. Pediatr Int 43:146–151PubMedCrossRef

29.

Thomas RL, Parker GC, Van Overmeire B, Aranda JV (2005) A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 164:135–140PubMedCrossRef

30.

Tschuppert S, Doell C, Arlettaz-Mieth R, Baenziger O, Rousson V, Balmer C et al (2008) The effect of ductal diameter on surgical and medical closure of patent ductus arteriosus in preterm neonates: size matters. J Thorac Cardiovasc Surg 135:78–82PubMedCrossRef

31.

Urquhart DS, Nicholl RM (2003) How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate? Arch Dis Child 88:85–86PubMedCrossRef

32.

Van Overmeire B (2007) Patent ductus arteriosus: how aggressive should we be? Neonatology 91:318CrossRef

33.

Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwe W, Jespers A et al (2004) Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 364:1945–1949PubMedCrossRef

34.

Van Overmeire B, Chemtob S (2005) The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med 10:177–184PubMedCrossRef

35.

Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K et al (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674–681PubMedCrossRef

Title: Patent Ductus Arteriosus in the Preterm Infant: A Survey of Clinical Practices in French Neonatal Intensive Care Units
Authors: Olivier Brissaud
Julie Guichoux
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Pediatric Cardiology / Issue 5/2011
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-011-9925-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Patent Ductus Arteriosus in the Preterm Infant: A Survey of Clinical Practices in French Neonatal Intensive Care Units

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2011

Idiopathic Ventricular Tachycardia in a Newborn: Immediate Response to Lidocaine

Acute Progressive Mitral Regurgitation Resulting From Chordal Rupture in Infants

The Neonatal But Not the Mature Heart Adapts to Acute Tachycardia by Beneficial Modification of the Force–Frequency Relationship

Familial Pseudocoarctation of the Aorta

Outcomes of Cardiac Transplantation in Highly Sensitized Pediatric Patients

Common Atrium and Pulmonary Vascular Disease